Small/medium drug companies seeking survival with R&D.

Small drug companies are trying the company transformation themselves to survive from the forthcoming challenges of the FTA and the positive list system.

It seems to be very likely for the local pharmaceutical industry to be restructured under the initiatives of large pharmaceutical companies where the R&D for new drugs and large scale of the manufacturing facilities are well established wh...